Cargando…

Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma

Esophageal cancer is one of the most common cancers worldwide. Esophageal squamous cell carcinoma (ESCC) is the major histological type of esophageal cancer in Eastern Asian countries. Several types of noncoding RNAs (ncRNAs) function as key epigenetic regulators of gene expression and are implicate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugihara, Hidetaka, Ishimoto, Takatsugu, Miyake, Keisuke, Izumi, Daisuke, Baba, Yoshifumi, Yoshida, Naoya, Watanabe, Masayuki, Baba, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661918/ https://www.ncbi.nlm.nih.gov/pubmed/26610479 http://dx.doi.org/10.3390/ijms161126060

Ejemplares similares

KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review
por: Shigaki, Hironobu, et al.
Publicado: (2012)

TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma
por: Murata, Asuka, et al.
Publicado: (2015)

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
por: Baba, Yoshifumi, et al.
Publicado: (2020)

UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma
por: Nakamura, Kenichi, et al.
Publicado: (2016)

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
por: Kalikawe, Rebecca, et al.
Publicado: (2019)

Identification of miR-30e* Regulation of Bmi1 Expression Mediated by Tumor-Associated Macrophages in Gastrointestinal Cancer
por: Sugihara, Hidetaka, et al.
Publicado: (2013)

Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications
por: Baba, Yoshifumi, et al.
Publicado: (2017)

LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis
por: Shigaki, Hironobu, et al.
Publicado: (2012)

Prognostic Value of Pretreatment Red Blood Cell Distribution Width in Patients With Esophageal Cancer Who Underwent Esophagectomy: A Retrospective Study
por: Yoshida, Naoya, et al.
Publicado: (2022)

PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma
por: Okadome, Kazuo, et al.
Publicado: (2021)

Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
por: Sawayama, Hiroshi, et al.
Publicado: (2019)

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review
por: Harada, Kazuto, et al.
Publicado: (2016)

Fusobacterium nucleatum in gastroenterological cancer: Evaluation of measurement methods using quantitative polymerase chain reaction and a literature review
por: Yamamura, Kensuke, et al.
Publicado: (2017)

Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer
por: Kiyozumi, Yuki, et al.
Publicado: (2019)

Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients
por: Nomoto, Daichi, et al.
Publicado: (2021)

Clinical Significance of Pretreatment Red Blood Cell Distribution Width as a Predictive Marker for Postoperative Morbidity After Esophagectomy for Esophageal Cancer: A Retrospective Study
por: Yoshida, Naoya, et al.
Publicado: (2021)

Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
por: Iwatsuki, Masaaki, et al.
Publicado: (2018)

Multiple skeletal muscle metastases from poorly differentiated gastric adenocarcinoma
por: Koga, Yuki, et al.
Publicado: (2015)

Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

Preoperative skeletal muscle status is associated with tumor‐infiltrating lymphocytes and prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer
por: Izumi, Daisuke, et al.
Publicado: (2019)

Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2016)

Conflicting metabolic alterations in cancer stem cells and regulation by the stromal niche
por: Yasuda, Tadahito, et al.
Publicado: (2021)

Small bowel perforation due to indistinguishable metastasis of angiosarcoma: case report and brief literature review
por: Uchihara, Tomoyuki, et al.
Publicado: (2016)

Pan-immune-inflammation Value and Prognosis in Patients With Esophageal Cancer
por: Baba, Yoshifumi, et al.
Publicado: (2021)

Multiple heterochronic gastrointestinal stromal tumors in the stomach detected 6 years after resection: a case report
por: Yasuda, Tadahito, et al.
Publicado: (2020)

Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers
por: Okadome, Kazuo, et al.
Publicado: (2020)

Gut microbiome in gastrointestinal cancer: a friend or foe?
por: Liu, Yang, et al.
Publicado: (2022)

Successful esophageal bypass surgery in a patient with a large tracheoesophageal fistula following endotracheal stenting and chemoradiotherapy for advanced esophageal cancer: case report
por: Miyata, Tatsunori, et al.
Publicado: (2012)

Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Precautions for avoiding pulmonary morbidity after esophagectomy
por: Yoshida, Naoya, et al.
Publicado: (2020)

Port site recurrence of esophageal adenocarcinoma after minimally invasive esophagectomy: a case report
por: Horino, Taichi, et al.
Publicado: (2020)

Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?
por: Yamashita, Kohei, et al.
Publicado: (2019)

Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2015)

Functional diversity of cancer‐associated fibroblasts in modulating drug resistance
por: Bu, Luke, et al.
Publicado: (2020)

A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer
por: Izumi, Daisuke, et al.
Publicado: (2019)

Thyroid metastasis from esophageal adenocarcinoma: a case report and literature review
por: Yumoto, Shinsei, et al.
Publicado: (2019)

Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer
por: Miyamoto, Yuji, et al.
Publicado: (2015)

Maf expression in human macrophages and lymph node sinus macrophages in patients with esophageal cancer
por: Takeya, Hiroto, et al.
Publicado: (2019)

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis
por: Sakamoto, Yuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lhhm00436iousoa77rjc18np0h